Hologic is up 0.16 percent despite modest market slide
 | By Ellen Johnson | Macroaxis Story |
This article is intended for all current Hologic investors and for investors considering a position in the company. I will inspect if investors should continue to be optimistic for the company outlook. Hologic is currently traded for44.01. The entity has historical hype elasticity of -0.13. The average price elasticity to hype of competition is about 0.09. The firm is projected to decline in value after the next headline with price expected to drop to 43.88. The average volatility of media hype impact on the company stock price is about 177.03%. The price decrease on the next news is expected to be -0.3% where as daily expected return is currently at -0.17%. The volatility of related hype on Hologic is about 257.89% with expected price after next announcement by competition of 44.1. Given the investment horizon of 30 days, the next projected press release will be in about 9 days. What is Hologic Target Price Odds to finish over Current Price? Based on normal probability distribution, the odds of Hologic to move above current price in 30 days from now is about 87.89%. The Hologic probability density function shows the probability of Hologic Stock to fall within a particular range of prices over 30 days . Given the investment horizon of 30 days, Hologic has beta of 0.6548 . This indicates as returns on market go up, Hologic average returns are expected to increase less than the benchmark. However during bear market, the loss on holding Hologic will be expected to be much smaller as well. Additionally, the company has a negative alpha implying that the risk taken by holding this equity is not justified. Hologic is significantly underperforming S&P 500.
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Gabriel Shpitalnik
The company retains Market Volatility (i.e. Beta) of 0.6548 which attests that as returns on market increase, Hologic returns are expected to increase less than the market. However during bear market, the loss on holding Hologic will be expected to be smaller as well. Even though it is essential to pay attention to Hologic current price history, it is always good to be careful when utilizing equity current price movements. Macroaxis philosophy towards determining future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Hologic exposes twenty-one different technical indicators which can help you to evaluate its performance. Hologic has expected return of -0.1677%. Please be advised to check out Hologic Coefficient Of Variation, Maximum Drawdown as well as the relationship between Maximum Drawdown and Skewness to decide if Hologic past performance will be repeated at some point in the near future. Earning per share calculations of the firm is based on official Zacks consensus of 7 analysts regarding Hologic future annual earnings. Given the historical accuracy of 93.29%, the future earnings per share of the company is estimated to be 1.93 with lowest and highest values of 1.9 and 2.0 respectively. Please note that this consensus of annual earnings estimates for the entity is an estimate of EPS before non-recurring items and including employee stock options expenses. The successful prediction of Hologic stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Hologic, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Hologic based on Hologic hews, social hype, general headline patterns, and widely used predictive technical indicators. We also calculate exposure to Hologic's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Hologic's related companies.
A focus of Hologic technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Hologic trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...
Use Technical Analysis to project Hologic expected Price
Hologic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Hologic Gross Profit
Hologic Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Hologic previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Hologic Gross Profit growth over the last 10 years. Please check Hologic's gross profit and other fundamental indicators for more details.
An Additional Perspective On Hologic
The company currently falls under 'Large-Cap' category with current market capitalization of 12.03B. Hologic price decrease over the last few months may raise some interest from investors. The Stock closed today at a share price of 42.995 on 1453466.000 in trading volume. The company executives were not very successful in positioning the corporation components to exploit market volatility in May. However, diversifying your holdings with Hologic or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 1.313. The below-average Stock volatility is a good sign for a longer term investment options and for buy-and-hold investors. Hologic maintains current liabilities of 39.47m. Hologic is trading at 44.01 which is 0.16 percent increase. Day Low was 42.995. Hologic Property Plant and Equipment Net is fairly stable at the moment. Hologic Selling General and Administrative Expense is fairly stable at the moment. Additionally, Hologic Debt to Equity Ratio is fairly stable at the moment. To conclude, we belive that Hologic is currently fairly valued with very small probability of distress in the next two years. Our overall buy-hold-sell recommendation on the company is Strong Hold.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Hologic. Please refer to our Terms of Use for any information regarding our disclosure principles.